Related Experiment Video
Updated: Apr 1, 2026
07:01
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
1.2K
Proteoglycan 4 is a diagnostic biomarker for COPD.
Kang-Yun Lee1, Hsiao-Chi Chuang2, Tzu-Tao Chen3
1Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan ; Department of Internal Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan.
International Journal of Chronic Obstructive Pulmonary Disease
|October 10, 2015
Summary
Proteoglycan 4 (PRG4) shows promise as a biomarker for identifying Chronic Obstructive Pulmonary Disease (COPD) severity. PRG4 levels correlate with disease progression and lung function decline in COPD patients.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Respiratory Disease Research
Background:
- C-reactive protein (CRP) is used to assess COPD stability but lacks specificity due to its association with other conditions.
- A need exists for a specific diagnostic biomarker for Chronic Obstructive Pulmonary Disease (COPD).
Purpose of the Study:
- To identify a novel diagnostic biomarker for COPD.
- To evaluate the efficacy of potential biomarkers in assessing COPD severity and predicting lung function decline.
Main Methods:
- A 1-year follow-up study involved 61 COPD patients and 15 healthy controls.
- Serum levels of Proteoglycan 4 (PRG4) and CRP were measured and compared.
- Receiver operating characteristic (ROC) analysis was used to determine biomarker sensitivity and specificity.
- Correlation between PRG4 levels and lung function decline was assessed.
Main Results:
- Proteoglycan 4 (PRG4) was identified as a potential biomarker for COPD.
- PRG4 serum concentrations were significantly higher in COPD patients (GOLD stages 1-4) compared to healthy controls and smokers (P<0.05).
- PRG4 demonstrated higher sensitivity and specificity than CRP for COPD severity and exacerbation frequency.
- PRG4 was negatively correlated with 1-year decline in forced vital capacity (FVC) (R²=0.91, P=0.013).
Conclusions:
- Proteoglycan 4 (PRG4) may serve as a valuable biomarker for identifying COPD severity.
- PRG4 levels are associated with the rate of lung function decline in COPD patients over a one-year period.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
01:05Proteoglycans
5.2K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.2K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
01:30Pneumonia III: Complications and Assessment
1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K